Evaluating thyme extract effect on clinical symptoms of children with allergic

Evaluating thyme extract effect on clinical symptoms of children with allergic rhinitis referred to allergy clinics of Urmia University of Medical Sciences

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150426021944N3

Enrollment

Registered

2023-03-19

Start date

2023-04-21

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Other allergic rhinitis

Interventions

Intervention 1: Intervention group: Thyme extract orally at a dose of 10 cc per day for 60 days. Intervention 2: Control group: Nasal spray Mometasone every 12 hours as standard treatment

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age lower than 12 years old The use of thyme medicine and intranasal spray are excellent

Exclusion criteria

Exclusion criteria: Not using thyme medicine and Mumtazoon intranasal spray Patients with non-allergic rhinitis Children with moderate to severe drug side effects Children suffering from other systemic diseases such as sinusitis and vautitis

Design outcomes

Primary

Measure	Time frame
Duration of hospitalization. Timepoint: Duration of treatment. Method of measurement: Length of hospitalization.	—

Secondary

Measure	Time frame
Medical allergy. Timepoint: Duration of treatment. Method of measurement: Clinical observations.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sohila Sadeghpour

Oroumia University of Medical Sciences

soheilasadeghpourazar@gmail.com+98 44 3344 4592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026